Litcius/Paper detail

Reactive oxygen species-scavenging hollow MnO<sub>2</sub> nanozymes as carriers to deliver budesonide for synergistic inflammatory bowel disease therapy

Huiqiang Qiu, Hengtai Gong, Yuheng Bao, Hong Jiang, Weijun Tong

2021Biomaterials Science46 citationsDOI

Abstract

carriers and anti-inflammatory drug by blocking the amplification effect of inflammation. In addition, compared with free Bud, the drug delivery system can reduce side effects of Bud and improve its treatment outcome at the same dosage. Therefore, this study provides a new method for the design of highly effective synergistic anti-inflammatory nanomedicines.

Topics & Concepts

Proinflammatory cytokineReactive oxygen speciesChemistryBudesonideInflammatory bowel diseasePharmacologyInflammationDrugBiochemistryImmunologyMedicineDiseasePathologyAsthmaAdvanced Nanomaterials in CatalysisNanoplatforms for cancer theranosticsNanocluster Synthesis and Applications
Reactive oxygen species-scavenging hollow MnO<sub>2</sub> nanozymes as carriers to deliver budesonide for synergistic inflammatory bowel disease therapy | Litcius